No Data
Express News | Over 30 A-share listed companies revealed the latest mergers, acquisitions and restructuring announcements this week, CNNC Technology plans to buy 71.965% of CNNC's shares and suspend trading tomorrow
Minsheng Health (301507): A century of Minsheng towards health, a new chapter of the Global Strategy.
With a century of history in Minsheng, the 21st Kinvi brand continues to shine, and the "Four New Global Strategy" points to the future direction. Minsheng Health Holdings' shareholder Minsheng Pharmaceutical was established in 1926 and is one of the earliest four major Western medicine manufacturers in China. The company's block orders are 2.
Express News | Minsheng Health: plans to acquire 100% of the shares of the symbol company through its wholly-owned subsidiary.
Express News | Minsheng Health: Signed a Global Strategy cooperation agreement with Zhongke Jiayi and other entities.
Minsheng Health (301507.SZ): The company and its wholly-owned subsidiary received a certificate for an invention patent.
On December 24, Gelonghui reported that Minsheng Health (301507.SZ) announced that recently, the company and its wholly-owned subsidiary Minsheng Zhongke Jiayi (Zhejiang) Biotechnology Co., Ltd. (formerly Zhejiang Minsheng Health Technology Co., Ltd.) received a certificate of invention patent issued by the National Intellectual Property Administration. The invention is titled "A method for extracting Vitamin K2 from a composite formulation of various Vitamins and Minerals," with a patent term of twenty years.
Express News | Minsheng Health: actively seeking new project opportunities in the big health field that are in line with the company's development global strategy and have rich synergies upstream and downstream.
